Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy.
about
Misregulation of the proline rich homeodomain (PRH/HHEX) protein in cancer cells and its consequences for tumour growth and invasionProteoglycans in liver cancerEndocan and the respiratory system: a reviewPrognostic value of endocan expression in cancers: evidence from meta-analysisIdentification of genes and pathways involved in retinal neovascularization by microarray analysis of two animal models of retinal angiogenesisGlycosaminoglycans in Human and Bovine Serum: Detection of Twenty-Four Heparan Sulfate and Chondroitin Sulfate Motifs Including a Novel Sialic Acid-modified Chondroitin Sulfate Linkage HexasaccharideSerum endocan levels in patients with chronic liver disease.Preconditioning serum levels of endothelial cell-derived molecules and the risk of posttransplant complications in patients treated with allogeneic stem cell transplantationHuman omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance.Characteristics of serum endocan levels in infection.Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromesEndocan: A new marker for cancer and a target for cancer therapy.Genomic and proteomic profiling I: leiomyomas in African Americans and CaucasiansEndothelial pentraxin 3 contributes to murine ischemic acute kidney injury.A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis.Serum endocan as a survival predictor for patients with liver cirrhosisGenome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profileTwo Bioactive Molecular Weight Fractions of a Conditioned Medium Enhance RPE Cell Survival on Age-Related Macular Degeneration and Aged Bruch's MembraneNeutrophil/Lymphocyte Ratio, Serum Endocan, and Nesfatin-1 Levels in Patients with Psoriasis Vulgaris Undergoing Phototherapy Treatment.Effect of CPAP on New Endothelial Dysfunction Marker, Endocan, in People With Obstructive Sleep Apnea.Expressions of Endocan in Patients with Meningiomas and GliomasPlasma endocan level and prognosis of immunoglobulin A nephropathy.Correlation between expression and differentiation of endocan in colorectal cancer.Molecular basis for impaired collateral artery growth in the spontaneously hypertensive rat: insight from microarray analysisEndocan immunoreactivity in the mouse brain: method for identifying nonfunctional blood vessels.Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics.Endocan as a prognostic biomarker of triple-negative breast cancer.Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma.Identification of fibroblast growth factor-18 as a molecule to protect adult articular cartilage by gene expression profiling.ESM1 mediates NGFR-induced invasion and metastasis in murine oral squamous cell carcinoma.Endothelium and regulatory inflammatory mechanisms during organ rejection.Markers for sepsis diagnosis in the forensic setting: state of the art.Endocan: a novel circulating proteoglycan.Endocan and Non-Dipping Circadian Pattern in Newly Diagnosed Essential Hypertension.Immunolocalization of endocan during the endothelial-mesenchymal transition process.Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan.Serum Endocan Levels in Children with Febrile Neutropenia.Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.Angiopoietin-2 Levels as Predictors of Outcome in Mechanically Ventilated Patients with Acute Respiratory Distress Syndrome.Systemic levels of the endothelium-derived soluble adhesion molecules endocan and E-selectin in patients with suspected deep vein thrombosis.
P2860
Q26766056-3CF2F04E-9B31-4778-BD93-F843390AF585Q26772304-E9A7C4ED-E61E-4BD5-BE92-D1C6EAADADC7Q28069363-A51AFB6F-92E9-4ECF-A69E-29D18CF4ED9AQ28075990-DFE7FD84-2144-4CB7-B3A1-2AA0BB756DE3Q33845347-BDEF7B44-5ADC-4A7C-B257-B26A3E5E5B30Q34016310-92B320A7-DDA8-4C9C-B994-75F6C333990FQ34042254-A3542805-E2F1-44E9-BC09-80E605659E59Q34390721-808B7522-D949-447E-90F5-31BF5E7FDD78Q35061366-EC649C6C-BFAB-4572-A6B6-E3AA71AA63DDQ35500737-7473CD3B-3804-4AB4-9876-0F6183B3A3D8Q35547367-AFAEA288-789E-43FD-A7A3-7AD4D357DA11Q35681482-BAE2F269-740D-42E7-863C-16E11735D194Q36116691-2EE3CDCA-636D-40B4-8A9A-DD91D91EEE9CQ36403585-94177413-2DD3-4B6C-A2E8-8A886D4B4B92Q36415707-2B7A488B-E9F7-4C85-B9FD-8946508931E7Q36425719-9D4507BC-E71E-4C80-9BF6-272C86100873Q36477174-9F7AAD57-7CC3-4E7B-9885-E3D6686E5B55Q36630592-1C712E3A-1A64-4674-8022-ABC1BE146604Q36797348-0E47EEA2-5E36-4A9F-A26B-3079535800EDQ36840271-88F3CAE9-FE3F-4F14-9D1A-998F595EFDF9Q37162853-6D98D1E2-5062-4456-9110-B18E6DE4BEFDQ37260183-D6B144F0-D50D-4507-8CD6-60AB4386AD1BQ37316926-3CDC96E0-408B-44F1-A33F-2BADCDF74DB1Q37319355-4ED10BFD-B0D8-4366-9C90-E4B6BBF60007Q37341628-3B052F4C-3089-48BF-BBBD-8DF728D5BCCCQ37564619-08FA55F0-4574-4E0B-AFD8-5FE867BE1612Q37578395-5D936BDF-8F20-491B-9CA2-143FFF459034Q37657319-D3333534-C048-4CD1-B659-428BBF8B1CF6Q37683320-B1341110-AC00-4185-9FF4-D001BD6BDA53Q37688603-38F21CD0-1F60-4278-8D21-723A9A5ED46BQ38103486-DD6CB5EA-BD93-469D-BF7C-6AAEFB6BC88BQ38207964-B0D2CD49-3036-4367-8839-2FCAEA313C3EQ38299725-D14CE867-369F-4E97-A93F-0E5EAB82F1D0Q38797262-95E207C2-3E7A-4543-902A-8D399BAD01D5Q39421834-BEEE2078-B9D5-4AC4-B141-0796B3977630Q39431959-5E9B67E8-5457-424A-AAB6-887B9B6060EDQ39738902-1ACB13DB-E83E-44DE-B084-F8B6BA3F5772Q41472390-1A2D328C-6312-440B-B2A9-B6116FAB13FEQ41691907-BE568912-3D3E-4A15-8E04-2B3AFE13B3ADQ41693572-4C14FFBA-223E-45EE-9506-2E9073E9328C
P2860
Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Endocan or endothelial cell sp ...... new target for cancer therapy.
@ast
Endocan or endothelial cell sp ...... new target for cancer therapy.
@en
type
label
Endocan or endothelial cell sp ...... new target for cancer therapy.
@ast
Endocan or endothelial cell sp ...... new target for cancer therapy.
@en
prefLabel
Endocan or endothelial cell sp ...... new target for cancer therapy.
@ast
Endocan or endothelial cell sp ...... new target for cancer therapy.
@en
P2093
P50
P1476
Endocan or endothelial cell sp ...... new target for cancer therapy
@en
P2093
C Landolfi
F Depontieu
H Lortat-Jacob
S Sarrazin
P356
10.1016/J.BBCAN.2005.08.004
P407
P577
2005-08-26T00:00:00Z